Therapeutic compositions, combinations, and methods of use
US11564927B2 · kind B2 · utility
0Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 25, 2019 |
| Grant date | Jan 31, 2023 |
| Priority date | — |
| Expiry date | Nov 25, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to methods comprising administering a FAK inhibitor and an immunotherapeutic agent such as anti-PD-1 or anti-PD-L1; that are useful in the treatment of abnormal cell growth, such as cancer, in mammals, especially humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.